GLP-1 Agonists Reduce Recurrent Atrial Fibrillation

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report investigators who say weight loss does not fully explain the benefit.

Read the full article here

Related Articles